Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2020 5
2021 3
2022 1
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
The calcium-sensing receptor modulates the prostaglandin E2 pathway in intestinal inflammation.
Gushchina V, Kupper N, Schwarzkopf M, Frisch G, Piatek K, Aigner C, Michel A, Schueffl H, Iamartino L, Elajnaf T, Manhardt T, Vlasaty A, Heffeter P, Bassetto M, Kállay E, Schepelmann M. Gushchina V, et al. Among authors: schueffl h. Front Pharmacol. 2023 Apr 20;14:1151144. doi: 10.3389/fphar.2023.1151144. eCollection 2023. Front Pharmacol. 2023. PMID: 37153788 Free PMC article.
Einbau von (Bioaktiven) Äquatorialen Liganden in Platin(IV)-Komplexe.
Kastner A, Schueffl H, Yassemipour PA, Keppler BK, Heffeter P, Kowol CR. Kastner A, et al. Among authors: schueffl h. Angew Chem Weinheim Bergstr Ger. 2023 Nov 13;135(46):e202311468. doi: 10.1002/ange.202311468. Epub 2023 Oct 13. Angew Chem Weinheim Bergstr Ger. 2023. PMID: 38516539 Free PMC article.
A novel EGFR inhibitor acts as potent tool for hypoxia-activated prodrug systems and exerts strong synergistic activity with VEGFR inhibition in vitro and in vivo.
Caban M, Koblmueller B, Groza D, Schueffl HH, Terenzi A, Tolios A, Mohr T, Mathuber M, Kryeziu K, Jaunecker C, Pirker C, Keppler BK, Berger W, Kowol CR, Heffeter P. Caban M, et al. Among authors: schueffl hh. Cancer Lett. 2023 Jul 1;565:216237. doi: 10.1016/j.canlet.2023.216237. Epub 2023 May 19. Cancer Lett. 2023. PMID: 37211067 Free article.
Insertion of (Bioactive) Equatorial Ligands into Platinum(IV) Complexes.
Kastner A, Schueffl H, Yassemipour PA, Keppler BK, Heffeter P, Kowol CR. Kastner A, et al. Among authors: schueffl h. Angew Chem Int Ed Engl. 2023 Nov 13;62(46):e202311468. doi: 10.1002/anie.202311468. Epub 2023 Oct 13. Angew Chem Int Ed Engl. 2023. PMID: 37703130 Free PMC article.
Structure-Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands.
Fronik P, Poetsch I, Kastner A, Mendrina T, Hager S, Hohenwallner K, Schueffl H, Herndler-Brandstetter D, Koellensperger G, Rampler E, Kopecka J, Riganti C, Berger W, Keppler BK, Heffeter P, Kowol CR. Fronik P, et al. Among authors: schueffl h. J Med Chem. 2021 Aug 26;64(16):12132-12151. doi: 10.1021/acs.jmedchem.1c00770. Epub 2021 Aug 17. J Med Chem. 2021. PMID: 34403254 Free PMC article.
Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis.
Groza D, Gehrig S, Kudela P, Holcmann M, Pirker C, Dinhof C, Schueffl HH, Sramko M, Hoebart J, Alioglu F, Grusch M, Ogris M, Lubitz W, Keppler BK, Pashkunova-Martic I, Kowol CR, Sibilia M, Berger W, Heffeter P. Groza D, et al. Among authors: schueffl hh. Oncoimmunology. 2018 Feb 16;7(5):e1424676. doi: 10.1080/2162402X.2018.1424676. eCollection 2018. Oncoimmunology. 2018. PMID: 29721389 Free PMC article.
18 results